Voda invests in medical company


Vodafone’s venture capital division has invested in T+ Medical, a company which uses mobile phones to transfer patient data onto a server for long term health conditions.

The investment will be used to roll out the mobile patient reported outcomes (mPRO) platform which is designed for clinical trials. Data is entered into the mobile by candidates taking the trial on a diary feature which is automatically downloaded onto the T+ server for analysis.

T+ Medical chief executive Tim Clover said: “The provision of healthcare services and clinical trials through mobile technology offers a scalable platform to allow large volumes of patient data to be securely transferred and analysed in real-time.

“This investment from Vodafone Ventures will help us to further drive the roll out of remote patient management solutions, to offer cost savings and improved clinical outcomes to customers around the world.”

Vodafone Ventures president Peters Suh said: “This investment will help to  ensure that T+ Medical is able to deliver on its potential while bringing greater scale to the mHealth market.”

Meanwhile, the network has teamed up with MTV to launch a competition to discover unsigned acts from 26 countries.

Entrants can upload their best tracks with pictures and biographies to the Vodafone Soundbites website. The winning act will have the opportunity to record a single and a produce professional music video to  be aired on MTV and Vodafone Live! which will be available in 18 European markets as well as Australia and New Zealand.

Vodafone Group global brand director David Wheldon said: “Following the success of Vodafone Music Reporter with MySpace, we continue to deliver unique music experiences to our customers across multiple platforms.

“Vodafone Fast-track reinforces Vodafone’s credibility in the music industry, creates exciting opportunities for our customers and at the same time strengthens our position as a global communications brand.”